Skip to Content

Conjugated estrogens topical Pregnancy and Breastfeeding Warnings

Conjugated estrogens topical is also known as: Premarin Vaginal, Synthetic Conjugated Estrogens A

Medically reviewed on January 10, 2018

Conjugated estrogens topical Pregnancy Warnings

Use is contraindicated.

US FDA pregnancy category: Not assigned

There are no controlled data in human pregnancy. There appears to be little or no increase in birth defects when estrogens and progestins are inadvertently used during early pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Conjugated estrogens topical Breastfeeding Warnings

Use is not recommended.

Excreted into human milk: Yes

Comments:
-Administration decreases the quantity and quality of breast milk.

See references

References for pregnancy information

  1. "Product Information. Premarin Vaginal (conjugated estrogens topical)." Wyeth Laboratories, Philadelphia, PA.

References for breastfeeding information

  1. "Product Information. Premarin Vaginal (conjugated estrogens topical)." Wyeth Laboratories, Philadelphia, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide